Literature DB >> 15837331

3-(2-Ethoxy-4-{4-[3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxy]butoxy}phenyl)propanoic acid: a brain penetrant allosteric potentiator at the metabotropic glutamate receptor 2 (mGluR2).

Rowena V Cube1, Jean-Michel Vernier, John H Hutchinson, Michael F Gardner, Joyce K James, Blake A Rowe, Herve Schaffhauser, Lorrie Daggett, Anthony B Pinkerton.   

Abstract

We have identified and synthesized a brain penetrant propanoic acid as an allosteric potentiator of the metabotropic glutamate receptor 2. Structure-activity relationship studies directed toward improving the potency, level of potentiation and brain penetration led to the discovery of 8 (EC50=1200 nM, 77% potentiation, 119% brain/plasma in rat, 20 mpk i.p., brain level of 5700 nM).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15837331     DOI: 10.1016/j.bmcl.2005.02.078

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

Review 1.  Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors.

Authors:  Craig W Lindsley; Kyle A Emmitte; Corey R Hopkins; Thomas M Bridges; Karen J Gregory; Colleen M Niswender; P Jeffrey Conn
Journal:  Chem Rev       Date:  2016-02-16       Impact factor: 60.622

2.  Discovery of Oxazolobenzimidazoles as Positive Allosteric Modulators for the mGluR2 Receptor.

Authors:  Robert M Garbaccio; Edward J Brnardic; Mark E Fraley; George D Hartman; Pete H Hutson; Julie A O'Brien; Brian C Magliaro; Jason M Uslaner; Sarah L Huszar; Kerry L Fillgrove; James H Small; Cuyue Tang; Yuhsin Kuo; Marlene A Jacobson
Journal:  ACS Med Chem Lett       Date:  2010-07-12       Impact factor: 4.345

Review 3.  Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential.

Authors:  Karen J Gregory; Elizabeth N Dong; Jens Meiler; P Jeffrey Conn
Journal:  Neuropharmacology       Date:  2010-07-14       Impact factor: 5.250

Review 4.  Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia.

Authors:  P Jeffrey Conn; Craig W Lindsley; Carrie K Jones
Journal:  Trends Pharmacol Sci       Date:  2008-12-06       Impact factor: 14.819

Review 5.  Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.

Authors:  P Jeffrey Conn; Arthur Christopoulos; Craig W Lindsley
Journal:  Nat Rev Drug Discov       Date:  2009-01       Impact factor: 84.694

6.  Optimizing Ligand Efficiency of Selective Androgen Receptor Modulators (SARMs).

Authors:  Anthony L Handlon; Lee T Schaller; Lisa M Leesnitzer; Raymond V Merrihew; Chuck Poole; John C Ulrich; Joseph W Wilson; Rodolfo Cadilla; Philip Turnbull
Journal:  ACS Med Chem Lett       Date:  2015-11-19       Impact factor: 4.345

7.  Allosteric modulators for mGlu receptors.

Authors:  F Gasparini; W Spooren
Journal:  Curr Neuropharmacol       Date:  2007-09       Impact factor: 7.363

8.  Design and synthesis of systemically active metabotropic glutamate subtype-2 and -3 (mGlu2/3) receptor positive allosteric modulators (PAMs): pharmacological characterization and assessment in a rat model of cocaine dependence.

Authors:  Raveendra-Panickar Dhanya; Douglas J Sheffler; Russell Dahl; Melinda Davis; Pooi San Lee; Li Yang; Hilary Highfield Nickols; Hyekyung P Cho; Layton H Smith; Manoranjan S D'Souza; P Jeffrey Conn; Andre Der-Avakian; Athina Markou; Nicholas D P Cosford
Journal:  J Med Chem       Date:  2014-05-09       Impact factor: 7.446

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.